Text Size

Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00757575
First received: September 19, 2008
Last updated: March 26, 2012
Last verified: March 2012
History of Changes

September 19, 2008
March 26, 2012
February 2008
October 2010   (final data collection date for primary outcome measure)
1.Describe the distribution of causal pathogen of meningitis and bacteremia 2.Estimate the hospital admission rate of pneumonia patients 3.Estimate the incidence rate of IPD 4.Describe the serotype distribution of S. pneumoniae [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Describe the distribution of causal pathogen of meningitis and bacteremia [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Estimate the hospital admission rate of pneumonia patients [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Estimate the incidence rate of IPD [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Describe the serotype distribution of S [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00757575 on ClinicalTrials.gov Archive Site
1.CFRof patients admitted with IPD and/or pneumonia. 2.Antibiotic resistance rate of S. pneumoniae 3.Risk factor distribution 4.Average duration of the hospitalization of patients with IPD, meningitis, and/or pneumonia. [ Time Frame: 2-3 years ] [ Designated as safety issue: No ]
  • CFRof patients admitted with IPD and/or pneumonia [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Antibiotic resistance rate of S. pneumoniae [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Risk factor distribution [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Average duration of the hospitalization of patients with IPD, meningitis, and/or pneumonia [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan
Epidemiological Surveillance Network Study To Assess the Disease of Pneumonia in Infants and Children in Japan

Streptococcus pneumoniae is a major cause of pneumonia, among infants and children in Japan and worldwideThis study plans to investigate the rate of invasive pneumococcal disease "IPD " and the rate of hospitalizations due to pneumonia in Okinawa and the Eastern half of Hokkaido Currently, only a limited information about pneumococcal disease burden is available in Japan.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Infants and children less than 5 years of age living in Okinawa and Eastern Hokkaido.
Pneumococcal Disease
Not Provided
1
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
28511
October 2010
October 2010   (final data collection date for primary outcome measure)

Eligibility Criteria

- Children residing in the surveillance area(s) aged 28 days to <60 months with clinical suspicion of pneumonia, meningitis and bacteremia who were admitted to the hospital.
Both
up to 60 Months
No
Contact information is only displayed when the study is recruiting subjects
Japan
 
NCT00757575
0887X1-4424
Yes
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP